Analysis of China's chemical API market prospects
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-06-25
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI China 2023 | At the Heart of Pharma
-
Pharmaceutical Equipment - Continued prosperous development, biologics market expansion brings important drivers
-
The Use Of Gas Chromatography In Pharmaceutical Industry
-
Lianhua Qingwen's Road to Internationalization is Getting Wider and Wider
-
The New Crown Antigen Self-Testing Products Were Approved For Marketing Who Can Self-Test?
-
The 15 Most Valuable Brands in the 2021 China Pharmaceutical Brand Value List
-
From the collective departure of Pfizer executives to see the impact of national collection on generic drug companies
-
Policy escalation to impact China's antibiotics market
-
Over 200 companies in the pharmaceutical industry performed well in 3Q
-
Chinese drug companies help secure global drug supply
Recommend Reading
-
FDA Approves Datopotamab Deruxtecan for Second Indication 45 Percent Response Rate in EGFR Mutant Lung Cancer
-
UK Parliament Approves Assisted Dying Bill 7500 Could Seek Euthanasia Annually
-
Over 100 Foreign Pharma Executives Join Chinese Firms in 5 Years Industry Faces Key Challenges
-
Merck’s New CMV Drug Approved in China Targets Nearly 40000 HSCT Patients
-
Roche Keeps German Diagnostics Investment
-
Insufficient Market Demand, DMF Market Prices Narrowly Fluctuate
-
“The Agency Revolution”: BASF Breaks Into Dongfeng Liuzhou’s Supply Chain
-
Supply Tightening, Melamine Market Shows Slight Rebound in China
-
Hormuz in Crisis: Freight Rates Surge to $6,000 as Global Trade Feels the Shock
-
Cyclohexane Market Faces Insufficient Demand, Prices Remain Stable